NeuroEM

07/30/2026

80% of people surveyed by the Alzheimer's Association expressed optimism that new treatment techniques will make a meaningful difference. This optimism is well-placed, writes NeuroEM CEO Chuck Papageorgiou, "because today’s biomedical innovators are going far beyond a drug-based approach, looking toward technology and non-invasive treatment modalities while eliminating previously insurmountable barriers, including limited effectiveness, high costs, and potentially dangerous side effects."

Read more from Chuck on HIT Consultant Media:

Of the medical diagnoses that cause anxiety, sorrow, and despair for patients and their loved ones, Alzheimer’s is near the top of the list.

07/22/2026

Did you know that managing 14 common health and lifestyle factors throughout our lives can prevent or delay 45% of cases? Supporting brain health requires continuous, fair access to healthy environments, education, and early healthcare from childhood onward. We are proud to join the World Federation of Neurology - WFN on to raise awareness of proactive prevention strategies and the need for care . 's
Learn more: wfneurology.org/world-brain-day

07/21/2026

Adding to the body of knowledge supporting continued whole-brain therapeutics, new research suggests the brain may lose its ability to adapt to change before the first obvious memory symptoms of 's appear.

The study from Texas A&M University Health Science Center suggests the brain’s capacity to change course, learn new rules, and adjust to unexpected situations may begin to decline before the memory problems most people associate with the disease.

New research suggests the brain may lose its ability to adjust to change before the first obvious memory symptoms appear.

07/04/2026

Celebrating 250 years of freedom on this 4th of July.

07/03/2026

What are members like Chuck Papageorgiou of NeuroEM saying about their StartUp Health experience?

Check out hundreds of
➡️ https://www.startuphealth.com/testimonials

Join the community now to get inside access to the conversations, connections, and events shaping health innovation. Everyone in the ecosystem is welcome!
➡️ https://startuphealth.com/

07/01/2026

NeuroEM CEO Chuck Papageorgiou notes that, of the 5 areas that drive brain health (biology, chemistry, physics, environment, behavior), investments to date have been directed to pharma solutions that slow the decline with some serious potential side effects. But there are physics-based solutions, like the impact on brain health of specific light and sound sequences via the optic or auditory pathways being developed by Cognito Therapeutics and and the impact of ultra-high frequencies developed by NeuroEM, that get very little attention and funding. We need to broaden the view of what's possible. https://ow.ly/MSGm50ZjkG6

06/18/2026

During today’s appearance on The Institute for Digital Transformation's Digital Dialogue, NeuroEM CEO Chuck Papageorgiou shared that brain health is increasingly complex and requires multidimensional attention in today’s digital age. Excessive reliance on AI for cognitive tasks could eventually affect mental vitality, leading Chuck to recommend that we find ways to keep our brains exercised and engaged.
,
The episode, Hope, Evidence, and Alzheimer’s Innovation, explored emerging technologies and personal experiences, examined the current state and future directions for ’s research, care, and prevention, and highlighted practical strategies for preserving brain health, the impact of social connection, and advances in neuromodulation therapies.

Listen to the full episode: https://ow.ly/bVFg50Ze2Ae

06/16/2026

Today's the day! NeuroEM sits down with Digital Dialogue at Noon ET to explore responsible innovation in brain health, including the importance of scientific evidence, regulatory rigor, and patient/caregiver needs, as promising technologies move from research toward real-world impact.

Join us for this timely episode focused on hope, evidence, and Alzheimer’s innovation. 's

Register here: https://www.linkedin.com/events/7468023403300618241/

06/12/2026

NeuroEM joins Digital Dialogue on June 16 for an important exploration of responsible innovation in brain health, including the importance of scientific evidence, regulatory rigor, and patient/caregiver needs as promising technologies move from research toward real-world impact. This timely episode will focus on hope, evidence, and ’s innovation. Register here: https://ow.ly/jCZs50Zb7h1

06/11/2026

NeuroEM joins the Institute for Digital Transformation on June 16 for an episode of Digital Dialogue focused on hope, evidence, and Alzheimer’s innovation. NeuroEM’s CEO Chuck Papageorgio, Community Advocate Patty Meagher, and Medical Advisor Dr. Christopher Rumana join host Kathryn Lancioni to explore the emerging conversation around NeuroEM and what its work may represent in the broader future of Alzheimer’s innovation.

This timely conversation will explore what responsible innovation looks like in brain health - including the importance of scientific evidence, regulatory rigor, and patient and caregiver needs as promising technologies move from research toward real-world impact - and what happens when a promising new medical technology captures attention and begins moving from research into the real world.

Register now: https://ow.ly/1Ae750ZaIQC